Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Statins
100%
Israel
87%
Israeli
82%
Acute Coronary Syndrome
65%
Internal Medicine Wards
55%
Low-density Lipoprotein Cholesterol (LDL-C)
50%
Lipid-lowering Therapy
49%
Hospitalized Patients
44%
Clinical Outcomes
41%
Low-density Lipoprotein Cholesterol Level
40%
Hospitalization
40%
Patient Outcomes
38%
Risk Factors
36%
Obesity
34%
Atrial Fibrillation
33%
Clinical Characteristics
33%
Coronary Heart Disease
30%
Coronary Patients
30%
Diabetic
29%
Fluorescence in Situ Hybridization
29%
Homozygous Familial Hypercholesterolemia (HoFH)
28%
Lipid Clinic
28%
Temporal Trends
28%
Chronic Lymphocytic Leukemia
28%
Clostridium Difficile Infection
28%
LDL-C Level
27%
30-day Mortality
27%
Congestive Heart Failure
26%
Internal Medicine
26%
Multiple Myeloma
26%
Warfarin
26%
Cholesterol Levels
25%
Clinical High Risk
25%
Influenza
24%
Demographic Characteristics
24%
Comorbidity
23%
Pre-diabetes (pre-DM)
23%
Renal Dysfunction
23%
Vascular Intervention
23%
Long-term Mortality
22%
Department of Medicine
22%
Secondary Prevention
21%
Retrospective Cohort Study
21%
Residual Risk
21%
Low-density Lipoprotein Cholesterol Goal
21%
High Risk
20%
Lymphoma Patients
20%
Peripheral Arterial Disease
20%
Venous Thromboembolism
19%
All-cause Mortality
19%
Medicine and Dentistry
Internal Medicine
75%
Low Density Lipoprotein Cholesterol
61%
Congestive Heart Failure
54%
Ischemic Heart Disease
51%
Familial Hypercholesterolemia
47%
Acute Coronary Syndrome
46%
Diseases
46%
Chemotherapy
44%
Lipid
44%
Statin
42%
Diabetes Mellitus
40%
Cardiovascular System
39%
Infection
39%
Non-Hodgkin Lymphoma
38%
Chronic Obstructive Pulmonary Disease
38%
Venous Thromboembolism
38%
Cardiovascular Disease
37%
Doxorubicin
30%
Myocardial Infarction
30%
Acute Decompensated Heart Failure
28%
Cardiovascular Risk
28%
Retrospective Cohort Study
27%
All Cause Mortality
25%
Mortality Rate
24%
Glucose
23%
Hodgkin's Lymphoma
23%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
22%
Atrial Fibrillation
22%
Secondary Prevention
21%
Warfarin
21%
Blood Glucose
20%
Arteriosclerosis Obliterans
20%
Odds Ratio
20%
Thromboprophylaxis
19%
Ejection Fraction
19%
Acute Heart Infarction
19%
Apixaban
19%
Alopecia Mucinosa
19%
Long Term Survival
19%
Cohort Effect
19%
Urinary Tract Infection
19%
B-Cell Chronic Lymphocytic Leukemia
19%
Patient with Non-Hodgkins Lymphoma
19%
Cholesterol
19%
Emergency Department
19%
Coronary Artery Disease
18%
Prospective Study
17%
Cohort Analysis
17%
Body Mass Index
16%
Multiple Myeloma
16%
Pharmacology, Toxicology and Pharmaceutical Science
Low Density Lipoprotein Cholesterol
98%
Lipid
94%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
72%
Statin (Protein)
71%
Familial Hypercholesterolemia
47%
Diseases
43%
Acute Coronary Syndrome
39%
Atrial Fibrillation
38%
Chronic Obstructive Lung Disease
38%
Placebo
32%
Congestive Heart Failure
31%
Diabetes Mellitus
29%
Infection
29%
Influenza
28%
Warfarin
28%
Monoclonal Antibody
24%
Cholesterol
24%
Anticoagulant Agent
24%
Cohort Study
24%
Cardiovascular Disease
23%
Tolerability
19%
Venous Thromboembolism
19%
Enalapril
19%
Apixaban
19%
Glucose
19%
All Cause Mortality
18%
High Density Lipoprotein Cholesterol
17%
Antilipemic Agent
17%
Kexin
17%
Bloodstream Infection
17%
Ezetimibe
17%
Cardiovascular Risk
16%
Morbidity
15%
Acetylsalicylic Acid
15%
Urinary Tract Infection
15%
Ischemic Heart Disease
14%
Enoxaparin
14%
Direct Oral Anticoagulant
14%
Atorvastatin
13%
Rosuvastatin
13%
Influenza A
13%
Retrospective Study
13%
Antibiotics
13%
Observational Study
12%
Prevalence
12%
Captopril
12%
Seasonal Influenza
12%
Proprotein Convertase 9
12%
Hypercholesterolemia
12%
Pneumonia
12%